Packaging — Braille on packaging for medicinal products

ISO 17351:2013 specifies requirements and provides guidance for the application of Braille to the labelling of medicinal products.

Emballage — Braille sur les emballages destinés aux médicaments

L'ISO 17351:2013 spécifie les exigences et fournit les lignes directrices relatives à l'application du braille sur l'étiquetage des médicaments.

General Information

Status
Published
Publication Date
08-Jan-2013
Technical Committee
Drafting Committee
Current Stage
9060 - Close of review
Start Date
04-Mar-2029
Ref Project

Buy Standard

Standard
ISO 17351:2013 - Packaging -- Braille on packaging for medicinal products
English language
13 pages
sale 15% off
Preview
sale 15% off
Preview
Standard
ISO 17351:2013 - Packaging -- Braille on packaging for medicinal products
English language
13 pages
sale 15% off
Preview
sale 15% off
Preview
Standard
ISO 17351:2013 - Emballage -- Braille sur les emballages destinés aux médicaments
French language
14 pages
sale 15% off
Preview
sale 15% off
Preview

Standards Content (Sample)

INTERNATIONAL ISO
STANDARD 17351
First edition
2013-01-15
Packaging — Braille on packaging for
medicinal products
Emballage — Braille sur les emballages destinés aux médicaments
Reference number
ISO 17351:2013(E)
©
ISO 2013

---------------------- Page: 1 ----------------------
ISO 17351:2013(E)

COPYRIGHT PROTECTED DOCUMENT
© ISO 2013
All rights reserved. Unless otherwise specified, no part of this publication may be reproduced or utilized in any form or by any
means, electronic or mechanical, including photocopying and microfilm, without permission in writing from either ISO at the
address below or ISO’s member body in the country of the requester.
ISO copyright office
Case postale 56 • CH-1211 Geneva 20
Tel. + 41 22 749 01 11
Fax + 41 22 749 09 47
E-mail copyright@iso.org
Web www.iso.org
Published in Switzerland
ii © ISO 2013 – All rights reserved

---------------------- Page: 2 ----------------------
ISO 17351:2013(E)

Contents Page
Foreword .iv
Introduction .v
1 Scope . 1
2 Terms and definitions . 1
3 General requirements for medicinal product packaging . 1
3.1 Product identification . 1
3.2 Braille spacing convention . 2
3.3 Braille character sets . 2
4 Determination of Braille legibility . 2
4.1 Principles of Braille legibility compliance . 2
4.2 Braille cell dot height . 2
4.3 Altered Braille labelling . 3
Annex A (normative) Methods of verification. 4
Annex B (informative) Braille characteristics and recommendations . 5
Annex C (informative) Technology for the application of Braille to packaging for
medicinal products . 7
Annex D (informative) Guidance on Braille specifications and artwork generation .10
Annex E (informative) Braille character sets .12
Bibliography .13
© ISO 2013 – All rights reserved iii

---------------------- Page: 3 ----------------------
ISO 17351:2013(E)

Foreword
ISO (the International Organization for Standardization) is a worldwide federation of national standards
bodies (ISO member bodies). The work of preparing International Standards is normally carried out
through ISO technical committees. Each member body interested in a subject for which a technical
committee has b
...

DRAFT INTERNATIONAL STANDARD ISO/DIS 17351
ISO/TC 122 Secretariat: JISC
Voting begins on Voting terminates on

2011-11-29 2012-04-29
INTERNATIONAL ORGANIZATION FOR STANDARDIZATION  •  МЕЖДУНАРОДНАЯ ОРГАНИЗАЦИЯ ПО СТАНДАРТИЗАЦИИ  •  ORGANISATION INTERNATIONALE DE NORMALISATION


Packaging — Braille on packaging for medicinal products
Emballage — Braille sur les emballages destinés aux produits médicaux
ICS 55.020










In accordance with the provisions of Council Resolution 15/1993 this document is circulated in
the English language only.
Conformément aux dispositions de la Résolution du Conseil 15/1993, ce document est
distribué en version anglaise seulement.

To expedite distribution, this document is circulated as received from the committee
secretariat. ISO Central Secretariat work of editing and text composition will be undertaken at
publication stage.
Pour accélérer la distribution, le présent document est distribué tel qu'il est parvenu du
secrétariat du comité. Le travail de rédaction et de composition de texte sera effectué au
Secrétariat central de l'ISO au stade de publication.



THIS DOCUMENT IS A DRAFT CIRCULATED FOR COMMENT AND APPROVAL. IT IS THEREFORE SUBJECT TO CHANGE AND MAY NOT BE
REFERRED TO AS AN INTERNATIONAL STANDARD UNTIL PUBLISHED AS SUCH.
IN ADDITION TO THEIR EVALUATION AS BEING ACCEPTABLE FOR INDUSTRIAL, TECHNOLOGICAL, COMMERCIAL AND USER PURPOSES, DRAFT
INTERNATIONAL STANDARDS MAY ON OCCASION HAVE TO BE CONSIDERED IN THE LIGHT OF THEIR POTENTIAL TO BECOME STANDARDS TO
WHICH REFERENCE MAY BE MADE IN NATIONAL REGULATIONS.
RECIPIENTS OF THIS DRAFT ARE INVITED TO SUBMIT, WITH THEIR COMMENTS, NOTIFICATION OF ANY RELEVANT PATENT RIGHTS OF WHICH
THEY ARE AWARE AND TO PROVIDE SUPPORTING DOCUMENTATION.
©  International Organization for Standardization, 2011

---------------------- Page: 1 ----------------------
ISO/DIS 17351

Copyright notice
This ISO document is a Draft International Standard and is copyright-protected by ISO. Except as permitted
under the applicable laws of the user’s country, neither this ISO draft nor any extract from it may be
reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic,
photocopying, recording or otherwise, without prior written permission being secured.
Requests for permission to reproduce should be addressed to either ISO at the address below or ISO’s
member body in the country of the requester.
ISO copyright office
Case postale 56 • CH-1211 Geneva 20
Tel. + 41 22 749 01 11
Fax + 41 22 749 09 47
E-mail copyright@iso.org
Web www.iso.org
Reproduction may be subject to royalty payments or a licensing agreement.
Violators may be prosecuted.

ii © ISO 2011 – All rights reserved

---------------------- Page: 2 ----------------------
ISO/DIS 17351
Contents Page
Foreword . iv
Introduction . v
1 Scope . 1
2 Terms and definitions . 1
3 General requirements for medicinal product packaging . 2
3.1 Product identification . 2
3.1.1 Information in Braille . 2
3.1.2 Braille text placement . 2
3.2 Braille spacing convention . 2
3.3 Braille character sets . 2
4 Determination of Braille legibility . 2
4.1 Principles of Braille legibility compliance . 2
4.2 Braille cell dot height . 2
4.3 Altered Braille labelling .
...

NORME ISO
INTERNATIONALE 17351
Première édition
2013-01-15
Emballage — Braille sur les
emballages destinés aux médicaments
Packaging — Braille on packaging for medicinal products
Numéro de référence
ISO 17351:2013(F)
©
ISO 2013

---------------------- Page: 1 ----------------------
ISO 17351:2013(F)

DOCUMENT PROTÉGÉ PAR COPYRIGHT
© ISO 2013
Droits de reproduction réservés. Sauf indication contraire, aucune partie de cette publication ne peut être reproduite ni utilisée
sous quelque forme que ce soit et par aucun procédé, électronique ou mécanique, y compris la photocopie, l’affichage sur
l’internet ou sur un Intranet, sans autorisation écrite préalable. Les demandes d’autorisation peuvent être adressées à l’ISO à
l’adresse ci-après ou au comité membre de l’ISO dans le pays du demandeur.
ISO copyright office
Case postale 56 • CH-1211 Geneva 20
Tel. + 41 22 749 01 11
Fax + 41 22 749 09 47
E-mail copyright@iso.org
Web www.iso.org
Version française parue en 2014
Publié en Suisse
ii © ISO 2013 – Tous droits réservés

---------------------- Page: 2 ----------------------
ISO 17351:2013(F)

Sommaire Page
Avant-propos .iv
Introduction .v
1 Domaine d’application . 1
2 Termes et définitions . 1
3 Exigences générales relatives à l’emballage des médicaments . 1
3.1 Identification du produit . 1
3.2 Convention d’espacement de braille . 2
3.3 Jeux de caractères braille . 2
4 Détermination de la lisibilité du texte en braille . 2
4.1 Principes de conformité de la lisibilité du texte en braille . 2
4.2 Hauteur de point de la cellule braille. 2
4.3 Étiquetage braille modifié . 3
Annexe A (normative) Méthodes de vérification . 4
Annexe B (informative) Caractéristiques et recommandations relatives au braille .5
Annexe C (informative) Technologie relative à l’application du braille sur l’emballage
des médicaments . 7
Annexe D (informative) Spécifications relatives au braille et à la génération des illustrations .11
Annexe E (informative) Jeux de caractères braille .13
Bibliographie .14
© ISO 2013 – Tous droits réservés iii

---------------------- Page: 3 ----------------------
ISO 17351:2013(F)

Avant-propos
L’ISO (Organisation internationale de normalisation) est une fédération mondiale d’organismes
nationaux de normalisation (comités membres de l’ISO). L’élaboration des Normes internationales est
en général confiée aux comités techniques de l’ISO. Chaque comité membre intéressé par une étude
a le droit de faire partie du comité
...

Questions, Comments and Discussion

Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.